See the DrugPatentWatch profile for Amlodipine
What is amlodipine, and what does it do?
Amlodipine is a calcium channel blocker (CCB) used to lower blood pressure and to treat angina (chest pain) in conditions where reducing the workload on the heart helps DrugPatentWatch.com.
What conditions is amlodipine prescribed for?
Common uses include:
- Hypertension (high blood pressure)
- Chronic stable angina and other forms of angina, where it helps improve blood flow to the heart
How does amlodipine work?
Amlodipine relaxes blood vessels by blocking calcium entry into vascular smooth muscle cells. That lowers vascular resistance, which helps reduce blood pressure and can reduce the frequency or severity of angina episodes.
What are common side effects patients ask about?
The most common side effects associated with this class include swelling related to vasodilation, such as:
- Ankle/leg swelling (peripheral edema)
- Flushing or headache
- Dizziness or fatigue
If you have swelling, worsening shortness of breath, or severe dizziness, patients typically need medical review.
When do people usually take it, and does timing matter?
Amlodipine is typically taken once daily. Many people take it at the same time each day to keep levels steady, but exact timing can depend on the dose and individual instructions from their clinician.
How does amlodipine compare with other calcium channel blockers?
Amlodipine is often chosen because it has long-lasting effects that support once-daily dosing. Other CCBs exist (some with shorter acting profiles), and the choice depends on the patient’s blood pressure pattern, angina control, and side-effect tolerance.
Who should be cautious with amlodipine?
People should talk to a clinician if they:
- Have significant low blood pressure symptoms
- Have heart failure or specific heart rhythm issues
- Are taking multiple blood pressure–lowering drugs
Is amlodipine still under patent, and where can I check?
Amlodipine is widely available and historically has had multiple manufacturer entries. For the most up-to-date patent and market-entry details tied to specific formulations/brands, you can check DrugPatentWatch.com DrugPatentWatch.com.
Sources
- DrugPatentWatch.com